Your browser doesn't support javascript.
loading
Diacylglycerol oil for the metabolic syndrome.
Yanai, Hidekatsu; Tomono, Yoshiharu; Ito, Kumie; Furutani, Nobuyuki; Yoshida, Hiroshi; Tada, Norio.
Afiliação
  • Yanai H; Department of Internal Medicine, The Jikei University School of Medicine, Chiba, Japan. yanaih@jikei.ac.jp
Nutr J ; 6: 43, 2007 Dec 11.
Article em En | MEDLINE | ID: mdl-18072966
ABSTRACT
Excess adiposity has been shown to play a crucial role in the development of the metabolic syndrome. The elevated fasting and postprandial triglyceride-rich lipoprotein levels is the central lipid abnormality observed in the metabolic syndrome. Recent studies have indicated that diacylglycerol (DAG) is effective for fasting and postprandial hyperlipidemia and preventing excess adiposity by increasing postprandial energy expenditure. We will here discuss the mechanisms of DAG-mediated improvements in hyperlipidemia and in postprandial energy expenditure, and effects of DAG oil on lipid/glucose metabolism and on body fat. Further, the therapeutic application of DAG for the metabolic syndrome will be considered.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome Metabólica / Diglicerídeos / Metabolismo Energético / Adiposidade / Hiperlipidemias Limite: Humans Idioma: En Revista: Nutr J Ano de publicação: 2007 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome Metabólica / Diglicerídeos / Metabolismo Energético / Adiposidade / Hiperlipidemias Limite: Humans Idioma: En Revista: Nutr J Ano de publicação: 2007 Tipo de documento: Article